Charles Schwab’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712K | Buy |
87,690
+8,195
| +10% | +$66.5K | ﹤0.01% | 3009 |
|
|
2025
Q1 | $560K | Buy |
79,495
+5,068
| +7% | +$35.7K | ﹤0.01% | 3044 |
|
|
2024
Q4 | $553K | Buy |
74,427
+13,922
| +23% | +$103K | ﹤0.01% | 3115 |
|
|
2024
Q3 | $298K | Hold |
60,505
| – | – | ﹤0.01% | 3285 |
|
|
2024
Q2 | $310K | Buy |
60,505
+50,078
| +480% | +$257K | ﹤0.01% | 3364 |
|
|
2024
Q1 | $55.4K | Hold |
10,427
| – | – | ﹤0.01% | 3358 |
|
|
2023
Q4 | $64.5K | Hold |
10,427
| – | – | ﹤0.01% | 3382 |
|
|
2023
Q3 | $78.7K | Hold |
10,427
| – | – | ﹤0.01% | 3371 |
|
|
2023
Q2 | $101K | Sell |
10,427
-59,401
| -85% | -$574K | ﹤0.01% | 3350 |
|
|
2023
Q1 | $264K | Hold |
69,828
| – | – | ﹤0.01% | 3115 |
|
|
2022
Q4 | $452K | Buy |
69,828
+1,836
| +3% | +$11.9K | ﹤0.01% | 3025 |
|
|
2022
Q3 | $605K | Buy |
67,992
+1
| +0% | +$9 | ﹤0.01% | 2946 |
|
|
2022
Q2 | $678K | Sell |
67,991
-199
| -0.3% | -$1.98K | ﹤0.01% | 2940 |
|
|
2022
Q1 | $790K | Buy |
68,190
+1,826
| +3% | +$21.2K | ﹤0.01% | 2946 |
|
|
2021
Q4 | $737K | Hold |
66,364
| – | – | ﹤0.01% | 3026 |
|
|
2021
Q3 | $612K | Sell |
66,364
-111,531
| -63% | -$1.03M | ﹤0.01% | 3069 |
|
|
2021
Q2 | $2M | Buy |
177,895
+5,057
| +3% | +$56.9K | ﹤0.01% | 2713 |
|
|
2021
Q1 | $1.83M | Buy |
172,838
+5,174
| +3% | +$54.9K | ﹤0.01% | 2686 |
|
|
2020
Q4 | $1.82M | Sell |
167,664
-3,413
| -2% | -$37K | ﹤0.01% | 2610 |
|
|
2020
Q3 | $1.66M | Sell |
171,077
-15,324
| -8% | -$149K | ﹤0.01% | 2555 |
|
|
2020
Q2 | $1.48M | Buy |
186,401
+14,257
| +8% | +$114K | ﹤0.01% | 2521 |
|
|
2020
Q1 | $1.5M | Buy |
172,144
+2,279
| +1% | +$19.8K | ﹤0.01% | 2381 |
|
|
2019
Q4 | $1.92M | Buy |
169,865
+5,863
| +4% | +$66.3K | ﹤0.01% | 2432 |
|
|
2019
Q3 | $1.78M | Buy |
164,002
+4,486
| +3% | +$48.8K | ﹤0.01% | 2418 |
|
|
2019
Q2 | $1.5M | Buy |
159,516
+4,760
| +3% | +$44.6K | ﹤0.01% | 2455 |
|
|
2019
Q1 | $1.9M | Buy |
154,756
+2,766
| +2% | +$34K | ﹤0.01% | 2376 |
|
|
2018
Q4 | $1.8M | Buy |
151,990
+960
| +0.6% | +$11.4K | ﹤0.01% | 2366 |
|
|
2018
Q3 | $2.18M | Buy |
151,030
+7,305
| +5% | +$105K | ﹤0.01% | 2403 |
|
|
2018
Q2 | $2.14M | Buy |
143,725
+22,475
| +19% | +$335K | ﹤0.01% | 2355 |
|
|
2018
Q1 | $1.58M | Buy |
121,250
+3,861
| +3% | +$50.4K | ﹤0.01% | 2402 |
|
|
2017
Q4 | $1.48M | Buy |
117,389
+5,148
| +5% | +$64.9K | ﹤0.01% | 2404 |
|
|
2017
Q3 | $1.45M | Buy |
112,241
+5,432
| +5% | +$70.4K | ﹤0.01% | 2402 |
|
|
2017
Q2 | $1.59M | Buy |
106,809
+589
| +0.6% | +$8.75K | ﹤0.01% | 2299 |
|
|
2017
Q1 | $1.28M | Buy |
106,220
+5,301
| +5% | +$63.6K | ﹤0.01% | 2352 |
|
|
2016
Q4 | $1.39M | Buy |
100,919
+4,774
| +5% | +$65.9K | ﹤0.01% | 2316 |
|
|
2016
Q3 | $1.29M | Buy |
96,145
+4,090
| +4% | +$54.9K | ﹤0.01% | 2322 |
|
|
2016
Q2 | $991K | Sell |
92,055
-19,784
| -18% | -$213K | ﹤0.01% | 2346 |
|
|
2016
Q1 | $1.18M | Buy |
111,839
+2,474
| +2% | +$26K | ﹤0.01% | 2274 |
|
|
2015
Q4 | $1.29M | Buy |
109,365
+3,702
| +4% | +$43.8K | ﹤0.01% | 2274 |
|
|
2015
Q3 | $1.23M | Buy |
105,663
+23,475
| +29% | +$274K | ﹤0.01% | 2307 |
|
|
2015
Q2 | $1.19M | Buy |
82,188
+2,214
| +3% | +$31.9K | ﹤0.01% | 2339 |
|
|
2015
Q1 | $1.12M | Buy |
79,974
+3,132
| +4% | +$43.7K | ﹤0.01% | 2326 |
|
|
2014
Q4 | $1.06M | Buy |
76,842
+1,647
| +2% | +$22.8K | ﹤0.01% | 2326 |
|
|
2014
Q3 | $922K | Buy |
75,195
+10,675
| +17% | +$131K | ﹤0.01% | 2335 |
|
|
2014
Q2 | $806K | Sell |
64,520
-416
| -0.6% | -$5.2K | ﹤0.01% | 2416 |
|
|
2014
Q1 | $725K | Buy |
64,936
+1,560
| +2% | +$17.4K | ﹤0.01% | 2434 |
|
|
2013
Q4 | $769K | Buy |
63,376
+1,942
| +3% | +$23.6K | ﹤0.01% | 2398 |
|
|
2013
Q3 | $754K | Buy |
61,434
+10
| +0% | +$123 | ﹤0.01% | 2349 |
|
|
2013
Q2 | $851K | Buy |
+61,424
| New | +$851K | ﹤0.01% | 2253 |
|